We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+0.7%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$11.9B
AUM Growth
+$136M
(+1.2%)
Cap. Flow
-$163M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
14.35%
Holding
967
New
43
Increased
432
Reduced
340
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VEON
VEON
|
+$92.2M |
| 2 |
Sensata Technologies
ST
|
+$48.4M |
| 3 |
Gilead Sciences
GILD
|
+$42.2M |
| 4 |
XYZ
Block Inc
XYZ
|
+$38.8M |
| 5 |
Bunge Global
BG
|
+$36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$43.1M |
| 2 |
PepsiCo
PEP
|
+$36M |
| 3 |
Cisco
CSCO
|
+$34.4M |
| 4 |
Merck
MRK
|
+$30.3M |
| 5 |
Simon Property Group
SPG
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 14.53% |
| 3 | Healthcare | 13.16% |
| 4 | Consumer Discretionary | 13.1% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Novartis
NVS
$297B
| $2.33M | 0.02% |
32,114
-4,269
| -12% | -$325K |
|
577
Loews
L
$23.6B
| $2.3M | 0.02% |
46,161
-25,955
| -36% | -$1.31M |
|
578
Bread Financial
BFH
$4.38B
| $2.29M | 0.02% |
13,502
+7,152
| +113% | +$1.4M |
|
579
East-West Bancorp
EWBC
$18B
| $2.29M | 0.02% |
36,562
-1,408
| -4% | -$92.4K |
|
580
Wendy's
WEN
$1.46B
| $2.29M | 0.02% |
130,224
-7,008
| -5% | -$116K |
|
581
Copart
CPRT
$27.5B
| $2.23M | 0.02% |
175,096
+71,388
| +69% | +$826K |
|
|
HOLX
582
DELISTED
Hologic
HOLX
| $2.21M | 0.02% |
59,163
+48,159
| +438% | +$1.95M |
|
583
United Therapeutics
UTHR
$23.1B
| $2.19M | 0.02% |
19,537
+11,269
| +136% | +$1.43M |
|
|
EVHC
584
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $2.19M | 0.02% |
57,029
+31,675
| +125% | +$1.18M |
|
585
Royal Caribbean
RCL
$85.6B
| $2.18M | 0.02% |
18,537
+725
| +4% | +$91.6K |
|
586
Camden Property Trust
CPT
$11.3B
| $2.18M | 0.02% |
25,914
-29,235
| -53% | -$2.44M |
|
587
Zoetis
ZTS
$30B
| $2.18M | 0.02% |
26,062
+5,669
| +28% | +$447K |
|
588
First Industrial Realty Trust
FR
$8.44B
| $2.17M | 0.02% |
74,132
-5,273
| -7% | -$156K |
|
589
MSC Industrial Direct
MSM
$6.86B
| $2.16M | 0.02% |
+23,594
| New | +$2.18M |
|
590
Sempra
SRE
$54.8B
| $2.16M | 0.02% |
38,918
-33,442
| -46% | -$1.8M |
|
591
Teva Pharmaceuticals
TEVA
$41.2B
| $2.14M | 0.02% |
+125,312
| New | +$2.45M |
|
592
Crown Castle
CCI
$32.2B
| $2.13M | 0.02% |
19,454
-1,584
| -8% | -$172K |
|
593
Varex Imaging
VREX
$523M
| $2.12M | 0.02% |
59,152
+9,100
| +18% | +$347K |
|
594
Dr. Reddy's Laboratories
RDY
$10.2B
| $2.07M | 0.02% |
317,060
+173,040
| +120% | +$1.21M |
|
595
Live Nation Entertainment
LYV
$42.1B
| $2.06M | 0.02% |
48,952
+6,236
| +15% | +$277K |
|
596
Dollar Tree
DLTR
$25.2B
| $2.02M | 0.02% |
21,288
+7,499
| +54% | +$786K |
|
597
Huntsman Corp
HUN
$1.77B
| $2.02M | 0.02% |
68,901
+35,780
| +108% | +$1.17M |
|
598
Citizens Financial Group
CFG
$30.6B
| $2.01M | 0.02% |
47,803
+27,477
| +135% | +$1.23M |
|
599
AerCap
AER
$23.8B
| $2M | 0.02% |
39,426
-10,771
| -21% | -$559K |
|
|
VISN
600
Vistance Networks Inc
VISN
$2.52B
| $1.99M | 0.02% |
49,702
-75,351
| -60% | -$2.94M |
|
Similar funds
BNP Paribas Asset Management's Q1 2018 Portfolio in Review
As of Q1 2018, BNP Paribas Asset Management held 967 positions worth $11.9B, up 1.2% from $11.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Asset Management's Q1 2018 filing shows 43 new, 432 increased, 340 reduced and 41 closed positions. Its largest new stake was Sensata Technologies: 908,783 shares worth $47.1M. The largest sale was Nike, an estimated $43.1M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- BNP Paribas Asset Management's largest Q1 2018 buy was Sensata Technologies: 908,783 shares worth $47.1M.
- BNP Paribas Asset Management added most to VEON in Q1 2018, an estimated $92.2M increase.
- BNP Paribas Asset Management's biggest Q1 2018 reduction was Nike, cutting an estimated $43.1M.
- BNP Paribas Asset Management fully exited Cavium, Inc. in Q1 2018, selling an estimated $12.7M.
- BNP Paribas Asset Management's ten largest holdings make up 14% of its $11.9B portfolio in Q1 2018.
- BNP Paribas Asset Management opened 43 new positions and closed 41 in Q1 2018.
- BNP Paribas Asset Management's portfolio value rose 1.2% quarter-over-quarter to $11.9B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2018, filed 7 May 2018.